Cargando…
Male hypogonadism: 14‐year prospective outcome in 550 men with type 2 diabetes
INTRODUCTION: Hypogonadism is more prevalent in men with type 2 diabetes (T2DM) (25%‐40%) than in men without T2DM. Hypogonadism has been associated with poorer glycaemic outcomes and increased cardiovascular morbidity/mortality. We report a 14‐year follow‐up study to evaluate the influence of basel...
Autores principales: | Malipatil, Nagaraj S., Yadegarfar, Ghasem, Lunt, Mark, Keevil, Brian, Siddals, Kirk, Livingston, Mark, Roberts, Siriol, Narayanan, Prakash, Rutter, Martin, Gibson, J. Martin, Donn, Rachelle, Hackett, Geoff, Jones, T. Hugh, Heald, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613223/ https://www.ncbi.nlm.nih.gov/pubmed/31294081 http://dx.doi.org/10.1002/edm2.64 |
Ejemplares similares
-
Methylation Status of Exon IV of the Brain-Derived Neurotrophic Factor (BDNF)-Encoding Gene in Patients with Non-Diabetic Hyperglycaemia (NDH) before and after a Lifestyle Intervention
por: Fachim, Helene A., et al.
Publicado: (2022) -
Lifestyle intervention in individuals with impaired glucose regulation affects Caveolin-1 expression and DNA methylation
por: Fachim, Helene A., et al.
Publicado: (2020) -
Data Independent Acquisition Mass Spectrometry Can Identify Circulating Proteins That Predict Future Weight Loss with a Diet and Exercise Programme
por: Malipatil, Nagaraj, et al.
Publicado: (2019) -
Serum testosterone levels in male hypogonadism: Why and when to check—A review
por: Livingston, Mark, et al.
Publicado: (2017) -
Dapagliflozin: an effective adjunctive treatment in type 1 diabetes
por: Yadegarfar, Ghasem, et al.
Publicado: (2021)